Vasopressor therapy in critically ill patients with shock.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2019 – Jul 2025Where it's discussed
-
X / Twitter227 posts
-
Facebook14 posts
-
YouTube2 videos
-
News2 articles
AI synopsis
What people are saying
The discussions surrounding the publication cover key points such as the first-choice use of norepinephrine for septic shock and inquiries about the appropriate management of vasopressors. Phrases like 'great article' and references to specific treatments show enthusiasm, while questions about dosing protocols indicate a desire to explore the implications of the research further. Such language and context highlight the urgency and relevance of the topic in critical care.
The majority of discussions reflect a consensus on the importance of the publication's findings regarding vasopressor therapy.
There is a high level of curiosity demonstrated, with many participants actively seeking to learn more about the topic and sharing relevant resources.
While some discussions are brief, several participants delve into specific aspects of vasopressor use and management, indicating some depth of engagement.
Many contributors believe that the publication has significant implications for clinical practice, particularly in critical care settings.
Abstract in brief
- Vasopressors are used primarily in critically ill patients with vasodilatory shock unresponsive to fluids, and their safety and effectiveness, along with the impact of associated treatments, have been reviewed.
- Research shows variations in vasopressor choice and dosing due to individual patient needs, with adverse effects that can include organ ischemia and hyperglycemia.
- Norepinephrine is the preferred vasopressor, with alternatives like vasopressin and epinephrine for patients not responding to it, while newer options like angiotensin II and predictive biomarkers may improve future treatments.
Top posts
Most liked on X and BlueskyVasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes: Intensive Care Med 2019; DOI: https://t.co/kGip0EIalK https://t.co/FrBNFWiFho
¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
Vasopressors are administered to patients in vasodilatory shock not responsive to volume resuscitation, and less commonly cardiogenic and hypovolemic shock. Norepinephrine as first choice. Vasopressor therapy in critically ill patients with shock
Vasopressor therapy in critically ill patients with shock https://t.co/3mAzHYmaki https://t.co/1TiBJZewgl
@nickmmark @MandyHutch70 A doubt, why first decrease norepinephrine than vasopressin? I had found this. Thanks! Intensive Care Med (2019) 45:1503–1517 https://t.co/rV5Ojwg9r4 https://t.co/fEfzUrDpJC
All mentions
Optimal Use of Vasopressors in Managing Critically Ill Patients
Vasopressors are crucial for treating critically ill patients with shock unresponsive to fluids. This video explores their safety and effectiveness, with a focus on norepinephrine as the preferred choice and…
Vasopressor Therapy in Critically Ill Patients: Key Insights
Vasopressors are essential in managing critically ill patients with shock. This video covers their safety, effectiveness, and variations in use based on individual needs. Norepinephrine is highlighted as the preferred…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
Vasopressor therapy in critically ill patients with shock | Intensive Care Medicine https://t.co/n4aKnAfh47
@OrlandoRPN 3.1) Hipotensión permisible con PAS 70-80 y PAM 50-60, mínimo 40mmHg, hasta control del origen del sangrado https://t.co/pRnT2tp9yA https://t.co/jhLupNhLps https://t.co/fVPZ0M0NmF
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
Terapia vasopresora en pacientes críticos con shock https://t.co/GviYt05INs
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
RT @FarMIC_SEFH: ¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
¿Sabes cual sería el manejo adecuado de los vasopresores en un pacientes con shock séptico?
Want to learn more about #vasopressors ? Check out this review ⬇️ #criticalmedboston https://t.co/svgOReeIAA
Links here: https://t.co/HysYJyhIA1. https://t.co/Rg1IJ3zeL2. https://t.co/txc0i0DsxH.
Vasopressor therapy in critically ill patients with shock https://t.co/AymT4qOlvh
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yodagreenemd: Vasopressors are administered to patients in vasodilatory shock not responsive to volume resuscitation, and less commonly…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @yourICM: Vasopressors in critically ill pts with shock: ➡️summary of evidence & pivotal trials ➡️relevant pathophysiology of vasodilato…
RT @FOAMecmo: Vasopressors in shock ➡️norepi 1st choice in septic/vasodilatory shock after volume #resuscitation, may be followed by vasopr…
Vasopressor therapy in critically ill patients with shock @ICS_updates #Intensive Care Med https://t.co/mKvr7L9An7
Vasopressor therapy in critically ill patients with #shock https://t.co/ImyuK2HY8w
RT @yodagreenemd: Vasopressors are administered to patients in vasodilatory shock not responsive to volume resuscitation, and less commonly…
Vasopressors are administered to patients in vasodilatory shock not responsive to volume resuscitation, and less commonly cardiogenic and hypovolemic shock. Norepinephrine as first choice. Vasopressor therapy in critically ill patients with shock
RT @mbrrio08: @nickmmark @MandyHutch70 A doubt, why first decrease norepinephrine than vasopressin? I had found this. Thanks! Intensi…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
RT @AmbrizMau: Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes:…
Vasopresores, su unión al receptor, posibles acciones beneficiosas adicionales, dosis y posibles biomarcadores relevantes: Intensive Care Med 2019; DOI: https://t.co/kGip0EIalK https://t.co/FrBNFWiFho
@nickmmark @MandyHutch70 A doubt, why first decrease norepinephrine than vasopressin? I had found this. Thanks! Intensive Care Med (2019) 45:1503–1517 https://t.co/rV5Ojwg9r4 https://t.co/fEfzUrDpJC
RT @PanicSong_: Vasopressor therapy in critically ill patients with shock https://t.co/3mAzHYmaki https://t.co/1TiBJZewgl
RT @PanicSong_: Vasopressor therapy in critically ill patients with shock https://t.co/3mAzHYmaki https://t.co/1TiBJZewgl
Vasopressor therapy in critically ill patients with shock https://t.co/3mAzHYmaki https://t.co/1TiBJZewgl
Vasopressor therapy in critically ill patients with shock https://t.co/cdSHjJar1Z
Vasopressor therapy in critically ill patients with shock. https://t.co/PEbk9oVcj4
#Vasopressor therapy in critically ill patients with #shock | SpringerLink https://t.co/S9aqkSs7Nl
Review: Vasopressor therapy in critically ill patients with shock. https://t.co/oUXRSiXB7H #ReadByQxMD
@DraSerotonina https://t.co/NmX5l3F556 Te paso el doi, con scihub se puede abri, no se como mandar documentos por TW
Vasopressor therapy in critically ill patients with shock. https://t.co/7gsCmjtgkX
Revisión de vasopresores Vasopressor therapy in critically ill patients with shock. https://t.co/RIQeKp1smp
#criticalcare Great article: Vasopressor therapy in critically ill patients with shock. https://t.co/6nK8AzQ1Ya #ReadByQxMD
Vasopressor therapy in critically ill patients with shock. - https://t.co/n6TEUlfBIs https://t.co/X5gOvSA2Kb
RT @laing_simon: Vasopressor therapy in critically ill patients with shock. - PubMed - #NCBI https://t.co/ebnzJYYelq
RT @laing_simon: Vasopressor therapy in critically ill patients with shock. - PubMed - #NCBI https://t.co/ebnzJYYelq
Vasopressor therapy in critically ill patients with shock. - PubMed - #NCBI https://t.co/ebnzJYYelq